BB-2116

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameBB-2116

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionMetalloproteases inhibitors

TargetsMetalloproteases

Therapy Area/IndicationsHIV Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesUnited Kingdom

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesBritish Biotech

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesBritish Biotech

Active IndicationsN/A

Inactive IndicationsHIV Infections

ATC CodeN/A